RSCI (Redwood Scientific Technologies) Cash-to-Debt: (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Redwood Scientific Technologies Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Redwood Scientific Technologies's cash to debt ratio for the quarter that ended in Dec. 2023 was .

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Redwood Scientific Technologies couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Redwood Scientific Technologies's Cash-to-Debt or its related term are showing as below:

RSCI's Cash-to-Debt is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.96
* Ranked among companies with meaningful Cash-to-Debt only.

Redwood Scientific Technologies  (OTCPK:RSCI) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Redwood Scientific Technologies Cash-to-Debt Related Terms

Redwood Scientific Technologies Cash-to-Debt Historical Data

* Premium members only.

The historical data trend for Redwood Scientific Technologies's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Redwood Scientific Technologies Cash-to-Debt Chart

Redwood Scientific Technologies Annual Data
Trend Dec16 Dec17 Dec21 Dec22 Dec23
Cash-to-Debt
0.16 0.31 - - -

Redwood Scientific Technologies Quarterly Data
Mar18 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

RSCI vs RAPH, FLGC, TXMD: Cash-to-Debt Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Redwood Scientific Technologies's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redwood Scientific Technologies Cash-to-Debt vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Redwood Scientific Technologies's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Redwood Scientific Technologies's Cash-to-Debt falls into.


Redwood Scientific Technologies Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Redwood Scientific Technologies's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Redwood Scientific Technologies had no debt (1).

Redwood Scientific Technologies's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Redwood Scientific Technologies had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redwood Scientific Technologies Business Description

Address 418 Broadway, STE 4872, Albany, NY, USA, 12207
Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets over-the-counter products in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products to market for stopping the addiction to nicotine.